NodesMigration into Draining Lymph CD73-Generated Adenosine Restricts

Krahn, Michael R. Blackburn and Linda F. ThompsonTanaka, Masayuki Miyasaka, Shinya Murakami, Thomas McGee, Emiko Maeda, Rodger P. McEver, ToshiyukiHiroyuki Oohara, Michelle L. Joachims, Stephanie T. Masahide Takedachi, Dongfeng Qu, Yukihiko Ebisuno,http://www.jimmunol.org/content/180/9/6288J Immunol€2008; 180:6288-6296; ;Referenceshttp://www.jimmunol.org/content/180/9/6288.full#ref-list-1This article cites 56 articles, 32 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  Beverly H. Koller,et al.  Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells* , 2000, The Journal of Biological Chemistry.

[2]  J. Linden,et al.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.

[3]  A. Zernecke,et al.  CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation , 2006, Circulation.

[4]  M. Idzko,et al.  Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. , 2003, Blood.

[5]  A. Verin,et al.  Regulation of endothelial barrier function by the cAMP-dependent protein kinase. , 2000, Endothelium : journal of endothelial cell research.

[6]  S. Colgan,et al.  Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function1 , 2000, The Journal of Immunology.

[7]  S. Jalkanen,et al.  CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73 , 1995, The Journal of experimental medicine.

[8]  Jonathan A. Rebhahn,et al.  T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine1 , 2006, The Journal of Immunology.

[9]  S. Jalkanen,et al.  IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation1 , 2004, The Journal of Immunology.

[10]  K. Miyake,et al.  Activation of CD44 induces ICAM‐1/LFA‐1‐independent, Ca2+, Mg2+, —independent adhesion pathway in lymphocyte‐endothelial cell interaction , 1993, European journal of immunology.

[11]  T. Eckle,et al.  A2B adenosine receptor dampens hypoxia-induced vascular leak. , 2008, Blood.

[12]  C. Boitard,et al.  Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL‐14 , 1994, European journal of immunology.

[13]  M. Moskowitz,et al.  A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.

[14]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[15]  J. Marth,et al.  Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment , 2007, Nature Immunology.

[16]  J. Linden.  Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[17]  Akiko Iwasaki,et al.  Innate control of adaptive immunity via remodeling of lymph node feed arteriole. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Mochizuki,et al.  Cyclic AMP Potentiates Vascular Endothelial Cadherin-Mediated Cell-Cell Contact To Enhance Endothelial Barrier Function through an Epac-Rap1 Signaling Pathway , 2005, Molecular and Cellular Biology.

[19]  B. Fredholm,et al.  The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. , 2003, Experimental cell research.

[20]  H. Mannherz,et al.  5'-Nucleotidase is involved in chick embryo myoblast spreading on laminin. , 1990, Cell biology international reports.

[21]  U. Dianzani,et al.  Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes. , 1993, Journal of immunology.

[22]  E. Butcher,et al.  Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.

[23]  L. Thompson,et al.  Regulation of adenosine receptor engagement by ecto‐adenosine deaminase , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  E. Ekland,et al.  Regulation of lymph node vascular growth by dendritic cells , 2006, The Journal of experimental medicine.

[25]  E. Butcher,et al.  Lymphocyte trafficking and regional immunity. , 1999, Advances in immunology.

[26]  A. Lucas,et al.  Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73). , 1990, Tissue antigens.

[27]  B. Cronstein.  Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[28]  M. Hegen,et al.  Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. , 1996, Journal of immunology.

[29]  Tianxin Yang,et al.  Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Koupenova,et al.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.

[31]  L. Thompson,et al.  CD73 expression and fyn‐dependent signaling on murine lymphocytes , 1998, European journal of immunology.

[32]  S. Colgan,et al.  Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.

[33]  B. Cronstein,et al.  The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. , 2007, Arthritis and rheumatism.

[34]  R. Mebius,et al.  High endothelial venules: lymphocyte traffic control and controlled traffic. , 1997, Advances in immunology.

[35]  C. Ledent,et al.  Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors , 2007, Circulation.

[36]  M. Fukuda,et al.  Nepmucin, a novel HEV sialomucin, mediates L-selectin–dependent lymphocyte rolling and promotes lymphocyte adhesion under flow , 2006, The Journal of experimental medicine.

[37]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[38]  M. Yacoub,et al.  Regulation of ecto-5′-nucleotidase by TNF-α in human endothelial cells , 2002, Molecular and Cellular Biochemistry.

[39]  A. Anderson,et al.  Microvascular changes in lymph nodes draining skin allografts. , 1975, The American journal of pathology.

[40]  R. Kannagi,et al.  A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules , 2005, Nature Immunology.

[41]  S. Colgan,et al.  Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.

[42]  M. Idzko,et al.  Expression and function of adenosine receptors in human dendritic cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  S. Rosen.  Ligands for L-selectin: homing, inflammation, and beyond. , 2004, Annual review of immunology.

[44]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[45]  C. Lluis,et al.  Enzymatic and extraenzymatic role of ecto‐adenosine deaminase in lymphocytes , 1998, Immunological reviews.

[46]  C. Ledent,et al.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. , 2002, The Journal of clinical investigation.

[47]  S. Jalkanen,et al.  CD73 Engagement Promotes Lymphocyte Binding to Endothelial Cells Via a Lymphocyte Function-Associated Antigen-1-Dependent Mechanism1 , 2000, The Journal of Immunology.

[48]  L. Thompson,et al.  Ecto‐enzyme and signaling functions of lymphocyte CD 7 3 , 1998, Immunological reviews.

[49]  E. Butcher,et al.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. , 1988, Journal of immunology.

[50]  H. Baker,et al.  Flagellin enhances NK cell proliferation and activation directly and through dendritic cell‐NK cell interactions , 2005, Journal of leukocyte biology.

[51]  N. Hogg,et al.  Lymphocyte Migration in Lymphocyte Function-associated Antigen (LFA)-1–deficient Mice , 1999, The Journal of experimental medicine.

[52]  H. Osswald,et al.  Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. , 2007, Journal of the American Society of Nephrology : JASN.

[53]  L. Thompson,et al.  Ecto-5′-Nucleotidase (CD73)-Mediated Adenosine Production Is Tissue Protective in a Model of Bleomycin-Induced Lung Injury1 , 2006, The Journal of Immunology.

[54]  L. Perrin,et al.  Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. , 1990, Journal of immunology.

[55]  K. Ley,et al.  Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. , 1994, Immunity.

[56]  P. Morris,et al.  Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 , 1995, The Journal of experimental medicine.